Trials / Completed
CompletedNCT01895114
Assessment of Renal Function in Cirrhotic Patients
Assessment of Renal Function in Cirrhotic Patients -A Comparison of Cystatin C and Creatinine Based Calculations to 125I-iothalamate
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 213 (actual)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to help determine whether cystatin C is a more sensitive laboratory measurement for renal function in cirrhotic patients.
Detailed description
Serum cystatin C, creatinine clearance based calculations, and 125I-Iothalamate clearance (Glofil) will be obtained in 220 patients with cirrhosis. Utilizing this information, the correlation between cystatin C and 125I-Iothalamate clearance will be obtained. In addition, the current serum creatinine based calculations and true creatinine clearance will also be correlated with 125I-Iothalamate clearance. The results of this study should help to determine whether serum cystatin C is a more sensitive laboratory measurement of renal function in patients with cirrhosis.
Conditions
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2021-04-01
- Completion
- 2025-01-13
- First posted
- 2013-07-10
- Last updated
- 2025-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01895114. Inclusion in this directory is not an endorsement.